These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30115481)

  • 21. Comparison of contemporary staging systems for oropharynx cancer in a surgically treated multi-institutional cohort.
    Elicin O; Broglie MA; Fankhauser N; Stoeckli SJ; Pasche P; Reinhard A; Bongiovanni M; Huber GF; Morand GB; Soltermann A; Arnold A; Dettmer MS; Arnoux A; Stauffer E; Espeli V; Martucci F; Aebersold DM; Giger R
    Head Neck; 2019 May; 41(5):1395-1402. PubMed ID: 30593685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilizing the AJCC 8
    Kim SI; Lee JW; Eun YG; Lee YC
    Anticancer Res; 2024 Apr; 44(4):1703-1710. PubMed ID: 38538003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Spector ME; Gallagher KK; Bellile E; Chinn SB; Ibrahim M; Byrd S; Chanowski EJ; Walline HM; Moyer JS; Prince ME; Wolf GT; Bradford CR; McHugh JB; Cordell K; Carey T; Worden FP; Eisbruch A; Chepeha DB
    Head Neck; 2014 Sep; 36(9):1233-40. PubMed ID: 23913653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
    Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
    BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition.
    Gurin D; Slavik M; Hermanova M; Shatokhina T; Sana J; Kazda T; Selingerova I; Ahmad P; Smilek P; Horakova Z; Hendrych M; Slampa P; Slaby O
    J Oral Pathol Med; 2018 Oct; 47(9):864-872. PubMed ID: 30079604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
    Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
    JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition.
    Miccio JA; Verma V; Kelly J; Kann BH; An Y; Park HS; Eskander A; Burtness B; Husain Z
    Oral Oncol; 2019 Dec; 99():104447. PubMed ID: 31630059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting Adverse Histopathology and Need for Postsurgical Adjuvant Therapy for Human Papilloma Virus-Associated Oropharynx Carcinoma.
    Ochoa E; Stanford-Moore G; Fakhry C; Ryan WR
    Otolaryngol Head Neck Surg; 2021 Aug; 165(2):309-316. PubMed ID: 33399518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
    Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
    Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
    Contrera KJ; Smile TD; Mahomva C; Wei W; Adelstein DJ; Broughman JR; Burkey BB; Geiger JL; Joshi NP; Ku JA; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman LM; Woody NM; Xiong D; Koyfman SA
    Oral Oncol; 2020 Dec; 111():105030. PubMed ID: 33038751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection.
    Yamashita Y; Ikegami T; Hirakawa H; Uehara T; Deng Z; Agena S; Uezato J; Kondo S; Kiyuna A; Maeda H; Suzuki M; Ganaha A
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):827-836. PubMed ID: 30594962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AJCC 8th Edition oral cavity squamous cell carcinoma staging - Is it an improvement on the AJCC 7th Edition?
    Pollaers K; Hinton-Bayre A; Friedland PL; Farah CS
    Oral Oncol; 2018 Jul; 82():23-28. PubMed ID: 29909897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of the 8th edition American Joint Committee on Cancer (AJCC) staging system in oral cavity squamous cell carcinoma.
    Moeckelmann N; Ebrahimi A; Tou YK; Gupta R; Low TH; Ashford B; Ch'ng S; Palme CE; Clark JR
    Oral Oncol; 2018 Oct; 85():82-86. PubMed ID: 30220324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
    Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer.
    Tang L; Ishikawa Y; Matsushita H; Jingu K
    Int J Clin Oncol; 2020 Aug; 25(8):1499-1505. PubMed ID: 32356049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph Node Ratio in HPV-Associated Oropharyngeal Cancer: Identification of a Prognostic Threshold.
    Bu DD; Ferrandino R; Robinson EM; Liu S; Miles BA; Teng MS; Yao M; Genden EM; Chai RL
    Laryngoscope; 2021 Jan; 131(1):E184-E189. PubMed ID: 32348558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.